Join Us! Free. Virtual.
2020 Hematology and Oncology Update
Conference Overview
This half-day symposium will serve as an update on a range topics, including benign hematology and malignant hematology; a COVID-19 cancer consortium; the role of geriatric oncology in treating older patients; targeted therapies, including proton therapy; and understanding the team approach to cancer care for better outcomes.
This symposium's target audience is primary care physicians. Other types of clinicians who may be interested: Oncology Physicians, Hospitalists, Advanced Practice Providers, Researchers, Oncology Nurses, Medical Students.
*Please note the new date of the conference is Saturday, October 24, 2020. The date is no longer Saturday, September 19, 2020.
Learning Objectives
1. Identify common causes of anemia and how to evaluate for these.
2. Recognize common hematologic complications of COVID infection and their implications/treatment
3. Recognize available treatments for AML and MDS, including how hematologists determine which treatments are appropriate
4. Learn tools used to assess effect of functional status and co-morbidities on cancer treatment toxicities and decision making in older patients
Accreditation
Inova CME Accreditation
The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to sponsor continuing medical education for physicians.
Credit Designation
The Inova Office of Continuing Medical Education designates this llive educational activity for a maximum of 4.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 4.5 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.
